Definitive Healthcare Corp. - Class A Common Stock, $0.001 par value (DH)

CUSIP: 24477E103

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+5,068,489
Put/Call ratio
76%
SEC-reported price per share
$10.33
Number of holders
139
Value change
+$50,921,386
Number of buys
96
Open additional details 1 more signal available
Number of sells
51
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
106,753,803

Security key

24477E103

Report period

Q1 2023

Institutions

139

Top holders

10

Ownership snapshot

Top reported holders of DH - Definitive Healthcare Corp. - Class A Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADVENT INTERNATIONAL, L.P.
Disclosed value leader
ADVENT INTERNATIONAL, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F 3/4/5 Highest disclosed value: $686,805,499 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ADVENT INTERNATIONAL, L.P. has the largest disclosed position value at $686.81M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADVENT INTERNATIONAL, L.P.'s linked filing trail.
Disclosed position value Top 5
ADVENT INTERNATIONAL, L.P. $686.81M
Christopher Egan $562.44M
Lauren Young $562.44M
Winn David Randall $78.8M
Echo Street Capital Management LLC $63.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADVENT INTERNATIONAL, L.P.
13F 3/4/5
Company · Director, 10%+ Owner
—
denominator unverified
$686,805,499
62,493,676 shares
— 31 Dec 2022
Christopher Egan
3/4/5
Director
—
denominator unverified
$562,443,084
62,493,676 shares
— 22 Nov 2021
Lauren Young
3/4/5
Director
—
denominator unverified
$562,443,084
62,493,676 shares
— 22 Nov 2021
Winn David Randall
3/4/5
Director
—
mixed-class rows
$78,797,091
2,472,433 shares
mixed-class rows
— 08 Aug 2022
Echo Street Capital Management LLC
13F
Company
13F
—
denominator unverified
$63,204,303
5,751,074 shares
— 31 Dec 2022
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$47,935,000
4,361,682 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
139
Shares
113,324,502
Rows available
139
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q2 2026 Across Filers

Q2 2026 holders
97
Q1 2023 holders
139
Holder diff
42
Investor Q2 2026 Shares Q1 2023 Shares Share Diff Share Chg % Q2 2026 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .